Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Huo, T.-I.
Right arrow Articles by Lee, S.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huo, T.-I.
Right arrow Articles by Lee, S.-D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1648-1653, 2003
© 2003 European Society for Medical Oncology


Original Paper

Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study

T.-I. Huo1,+, Y.-H. Huang1, J.-C. Wu1, J.-H. Chiang2, P.-C. Lee1, F.-Y. Chang1 and S.-D. Lee1

1 Department of Medicine, 2 Department of Radiology, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, Republic of China

Received 14 May 2003; revised 11 June 2003; accepted 11 August 2003

Background:

Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective treatments for hepatocellular carcinoma (HCC). We have conducted a prospective study to compare the efficacy of sequential TACE and PAI (TACE-PAI) versus repeated PAI therapy for HCC.

Patients and methods:

A total of 108 HCC patients with tumor size <=5 cm were enrolled. Fifty-three patients were treated with TACE–PAI and 55 patients were treated with PAI alone.

Results:

Objective responses were achieved in 72 of 80 nodules (90%) in the TACE–PAI group compared with 51 of 62 nodules (82%) in the PAI group (P = 0.217) during 24 ± 10 months of follow-up. Patients in the TACE–PAI group had a significantly lower cumulative tumor recurrence rate from the treated nodule (P = 0.004) or newly developed tumor elsewhere in liver (P = 0.010). Complete tumor necrosis in large (3–5 cm) HCCs was more frequently encountered in the TACE–PAI group (64% versus 37%; P = 0.034). There was no significant survival difference between the two groups with small (<=3 cm) HCC (P = 0.569), whereas PAI therapy was an independent poor prognostic predictor [relative risk 3.0 (95% confidence interval 1.2–7.6); P = 0.017] in the large HCC group.

Conclusions:

Sequential therapy with TACE and PAI is superior to repeated PAI alone for patients with large HCC.

Key words: arterial embolization, hepatocellular carcinoma, liver cirrhosis, percutaneous acetic acid injection


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
T.-I. Huo, Y.-H. Huang, J.-C. Wu, P.-C. Lee, F.-Y. Chang, and S.-D. Lee
Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study
Ann. Onc., May 1, 2004; 15(5): 775 - 780.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.